The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
about
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.Comparative proteomics as a tool for identifying specific alterations within interferon response pathways in human glioblastoma multiforme cells.Targeting Autophagy for Oncolytic Immunotherapy.
P2860
The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
@en
type
label
The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
@en
prefLabel
The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
@en
P2860
P356
P1433
P1476
The role of oncolytic virus immunotherapies to subvert cancer immune evasion.
@en
P2093
Meghan L Verschoor
Samuel T Workenhe
P2860
P304
P356
10.2217/FON.14.254
P407
P577
2015-02-01T00:00:00Z